BioLine RX Ltd (NASDAQ:BLRX)
| 1.94 Data as of Jul 28 |  +0.0099 / +0.51%Today’s Change | 1.79 Today|||52-Week Range 3.34 | -30.96% Year-to-Date |
Latest BLRX News | Press Releases
No recent news for BioLine RX Ltd.
Today’s Trading
| Previous close | 1.93 |
| Today’s open | 1.95 |
| Day’s range | -- - -- |
| Volume | 75,107 |
| Average volume (3 months) | 92,960 |
| Market cap | $66.2M |
| Dividend yield | -- |
Data as of 07/28/2014
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MSTXMast Therapeutics In... | -0.03 | -4.92% |
| IPCIIntelliPharmaCeutics... | +0.03 | +1.06% |
| AVEOAveo Pharmaceuticals... | +0.02 | +1.60% |
| OGENOragenics Inc | -0.02 | -1.07% |
Data as of 07/28/2014
Financials
| Next reporting date | August 26, 2014 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
Forecasts
.
